Now showing items 1-2 of 2
Valuing people with sickle cell disease
Employers need to be flexible when managing sickle cell disease in the workplace and sensitive to the risks of discrimination. Diana De, Simon Dyson and Karl Atkin offer evidence-based guidance and recommendations.
Resignifing the sickle cell gene: narratives of genetic risk, impairment and repair
Connecting theoretical discussion with empirical qualitative work, this paper examines how sickle cell became a site of public health intervention in terms of ‘racialised’ risks. Historically, sickle cell became socio-politically ...